Recherche
-
Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic Approach
(Antibiotics. vol. 11, n° 9, 2022-09-03)Article de revueLibre accès -
An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
(Allergy, Asthma and Clinical Immunology. vol. 14, pp. 38, 2018-09-24)Article de revueLibre accès -
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
(Cardiovascular Diabetology. vol. 20, n° 1, pp. 229, 2021-11-25)Article de revueLibre accès -
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
(Stroke. vol. 50, n° 9, pp. 2469-2476, 2019)Article de revueLibre accès -
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
(EP-Europace. vol. 22, n° 2, pp. 205-215, 2020)Article de revue -
Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI
(Thérapie. vol. 74, n° 4, pp. 459-468, 2019-09)Article de revue -
Treatment resistant depression incidence and prevalence using the French nationwide claims database
(Pharmacoepidemiology and Drug Safety. vol. 30, n° 2, pp. 169–177, 2021-02)Article de revue -
Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
(European Heart Journal. vol. 39, pp. 1014-1014, 2018-08)Article de revue -
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
(British Journal of Cancer. vol. 121, n° 12, pp. 1001-1008, 2019-12)Article de revueLibre accès -
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)
(Frontiers in Pharmacology. vol. 12, pp. 682890, 2021-11-03)Article de revueLibre accès